In the first talcum powder trial to take place since the COVID-19 pandemic shuttered courthouses, an Illinois jury came back July 30 with a defense verdict. Three talc trials followed, in Pennsylvania, Missouri and Georgia, and all the juries sided with Johnson & Johnson.

The string of losses is a marked departure for attorneys representing ovarian cancer victims, who, although they haven’t won every time, have collected awards of tens of millions, even $4.7 billion, prior to the pandemic.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]